HK1199930A1 - 相互作用的調節劑及其在治療癌症中的用途 - Google Patents
相互作用的調節劑及其在治療癌症中的用途Info
- Publication number
- HK1199930A1 HK1199930A1 HK15100387.4A HK15100387A HK1199930A1 HK 1199930 A1 HK1199930 A1 HK 1199930A1 HK 15100387 A HK15100387 A HK 15100387A HK 1199930 A1 HK1199930 A1 HK 1199930A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- astrin
- raptor
- modulators
- interaction
- cancer therapy
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13151022.4A EP2755027B1 (en) | 2013-01-11 | 2013-01-11 | Modulators of the interaction of astrin and raptor, and uses thereof in cancer therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1199930A1 true HK1199930A1 (zh) | 2015-07-24 |
Family
ID=47563201
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15100387.4A HK1199930A1 (zh) | 2013-01-11 | 2015-01-14 | 相互作用的調節劑及其在治療癌症中的用途 |
Country Status (6)
Country | Link |
---|---|
US (1) | US10041933B2 (zh) |
EP (1) | EP2755027B1 (zh) |
JP (1) | JP6494112B2 (zh) |
ES (1) | ES2588778T3 (zh) |
HK (1) | HK1199930A1 (zh) |
WO (1) | WO2014108532A1 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11237168B2 (en) * | 2019-06-26 | 2022-02-01 | St. Jude Children's Research Hospital | Method for identifying modulators of G3BP activity |
CN110476877A (zh) * | 2019-08-15 | 2019-11-22 | 上海交通大学医学院附属瑞金医院 | 一种β细胞中特异性Raptor敲除同时GFP示踪的小鼠的制备方法 |
CN113125747B (zh) * | 2021-03-15 | 2022-06-14 | 天津医科大学 | 一种isPLA-Seq的高通量检测蛋白质相互作用的方法和试剂盒及其应用 |
-
2013
- 2013-01-11 ES ES13151022.4T patent/ES2588778T3/es active Active
- 2013-01-11 EP EP13151022.4A patent/EP2755027B1/en active Active
-
2014
- 2014-01-13 JP JP2015552068A patent/JP6494112B2/ja not_active Expired - Fee Related
- 2014-01-13 US US14/758,461 patent/US10041933B2/en not_active Expired - Fee Related
- 2014-01-13 WO PCT/EP2014/050460 patent/WO2014108532A1/en active Application Filing
-
2015
- 2015-01-14 HK HK15100387.4A patent/HK1199930A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US20150355166A1 (en) | 2015-12-10 |
JP2016511822A (ja) | 2016-04-21 |
JP6494112B2 (ja) | 2019-04-03 |
EP2755027A1 (en) | 2014-07-16 |
ES2588778T3 (es) | 2016-11-04 |
US10041933B2 (en) | 2018-08-07 |
WO2014108532A1 (en) | 2014-07-17 |
EP2755027B1 (en) | 2016-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL304851A (en) | Tazematostat in combination with an acceptable treatment factor for use in the treatment of cancer | |
HK1216991A1 (zh) | 癌疫苗及使用其的治療方法 | |
ZA201505735B (en) | Cancer drug and uses | |
HK1221178A1 (zh) | 卡博替尼劑型及其在癌症治療中的使用 | |
EP3043819A4 (en) | Anti-vstm5 antibodies and the use thereof in therapy and diagnosis | |
GB201322725D0 (en) | Cancer therapy | |
HK1220900A1 (zh) | 癌症的治療 | |
EP2994148B8 (en) | Cancer therapy | |
ZA201607581B (en) | Dosage forms and therapeutic uses l-4lchlorokynurenine | |
EP2961412A4 (en) | CANCER THERAPY | |
HK1199930A1 (zh) | 相互作用的調節劑及其在治療癌症中的用途 | |
EP3007704A4 (en) | Combination therapy | |
EP3143036C0 (en) | PAR-1 BASED THERAPEUTIC CONJUGATES AND USES THEREOF | |
EP3068411A4 (en) | Oncolytic viruses and increased cancer treatment regimens | |
GB201308753D0 (en) | Compounds and their use in therapy | |
GB2510477B (en) | Formulations for use in the treatment of chronic fatigue and associated conditions, etc | |
EP2968398B8 (en) | Modified hyaluronan and uses thereof in cancer treatment | |
HK1209033A1 (zh) | 奧地帕西在治療黏多醣症病中的應用 | |
EP3071207A4 (en) | Libido-enhancing therapeutic and use | |
GB201312128D0 (en) | Drug combination and its use in therapy | |
GB201312129D0 (en) | Drug combination and its use in therapy | |
GB201312131D0 (en) | Drug combination and its use in therapy | |
GB201308217D0 (en) | Compounds and their use in therapy | |
GB201511158D0 (en) | Cell modification and application in therapy | |
AU2014903031A0 (en) | Nanoparticle Composition and Uses in Photodynamic Therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20220114 |